Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies

Persistent cough is a problematic symptom in many disease areas that negatively impacts quality of life, and often correlates with disease progression and prognosis, making it an important symptom to track and address. However, obtaining accurate measures of cough over time has been a challenge hindering treatment development, including a high susceptibility of cough to placebo effects.

In this session of Digital Health Monthly, we’ll focus on how digital measures provide an opportunity for continuous, objective cough monitoring that can address challenges like high placebo responses. You’ll learn how more accurate measures of cough can advance clinical research and development in respiratory diseases such as COPD, asthma, pulmonary fibrosis, and chronic cough.

Our guest experts will review the history and current state of cough monitoring, including:

• What drives the placebo response in cough and how this impacts measurements
• New insights from continuous cough monitoring
• Opportunities to assess cough symptoms alongside sleep and activity data from multisensor wearable DHTs

Speakers